Avril Lavigne – Head Above Water (Lyric Video)

Video Created by: Jonah Best
Produced by: Magic Seed Productions

Lyrics:
I’ve gotta keep the calm before the storm
I don’t want less
I don’t want more
Must bar the windows and the doors
To keep me safe to keep me warm

Yeah my life is what I’m fighting for
Can’t part the sea
Can’t reach the shore
And my voice becomes the driving force
I won’t let this pull me overboard

God keep my head above water
Don’t let me drown
It gets harder
I’ll meet you there at the altar
As I fall down to my knees
Don’t let me drown
Don’t let me drown

So pull me up from down below
‘Cause I’m underneath the undertow
Come dry me off and hold me close
I need you now I need you most

God keep my head above water
Don’t let me drown
It gets harder
I’ll meet you there at the altar
As I fall down to my knees
Don’t let me drown
Don’t let me drown
Don’t let me drown
Keep my head above water above water

And I can’t see in the stormy weather
I can’t seem to keep it all together
And I can’t swim the ocean like this forever
And I can’t breathe

God keep my head above water
I lose my breath at the bottom
Come rescue me
I’ll be waiting
I’m too young to fall asleep

God keep my head above water
Don’t let me drown
It gets harder
I’ll meet you there at the altar
As I fall down to my knees
Don’t let me drown
Don’t let me drown
Don’t let me drown
Keep my head above water above water

To find resources on Lyme Disease PREVENTION, educate yourself on doctors and TREATMENT, learn more about the most current scientific RESEARCH…and JOIN OUR FIGHT AGAINST LYME,

Visit http://www.TheAvrilLavigneFoundation.org

https://www.nejm.org/doi/full/10.1056/NEJMicm1801531

Glandular Tularemia

  • Laura Marks, M.D., Ph.D.,
  • and Andrej Spec, M.D.
nejmicm1801531_f1

A 68-year-old man from Missouri presented to the primary care clinic with a history of 1 week of fever followed by 2 months of progressive, painful swelling on the right side of his neck. Approximately 2 days before the onset of the patient’s symptoms, his outdoor cat died from a subacute illness; a veterinarian had diagnosed feline leukemia without laboratory testing, and the cat had been treated with prednisone, which the patient administered. The patient’s physical examination revealed three erythematous, tender lymph nodes. The remainder of the physical examination was normal. Serologic testing with IgM antibody was positive for Francisella tularensis (titer, 1:1280). A diagnosis of glandular tularemia was made. Glandular tularemia is the second most common manifestation of tularemia after the ulceroglandular form. Because culture requires biosafety level 3 conditions, diagnosis is often confirmed serologically. Domestic cats can become infected through the consumption of infected prey and can transmit the bacteria to humans. The patient was treated with doxycycline for 4 weeks; the lesions improved within 5 days and resolved within 3 weeks.


Laura Marks, M.D., Ph.D.
Barnes–Jewish Hospital, St. Louis, MO

Andrej Spec, M.D.
Washington University in St. Louis, St. Louis, MO

___________________

 

**Comment**

I remember hearing Timothy Lepore, MD, FACS, surgeon at Nantucket Cottage Hospital, at a Lyme conference.  He explained that Tularemia is also a disease of those who work with the land such as landscapers and farmers, as well as those who get bit by a tick. There are cases reported in every state but Hawaii, and many other wild and domestic animals can be infected. The highest rates of infection are in Arkansas.  Please see this link for more details but know that this is a bioweaponized pathogen:  https://madisonarealymesupportgroup.com/2016/10/25/of-rabbits-and-men/  The WHO estimates that an aerosol dispersal of 50 kg of F. tularensis over an area with 5 million people would result in 25,000 incapacitating casualties including 19,000 deaths.

For hunters:  https://madisonarealymesupportgroup.com/2018/08/07/tularemia-hunting-dogs-as-possible-vectors/  “The frequency of about seven percent shows that hunting dogs can also become infected regularly. As vectors of the disease, even without symptoms, the animals must also be considered unexpected carriers,” Posautz adds.

Approx. 4 Min.

_______________

**Comment** 

We shouldn’t be eating hardly anything presented here.  The apple, natural honey, butter, mayo, and cottage cheese are about it.

For homemade mayo.  Makes 2 1/2 C.  Put all into blender:

2 eggs

1 tsp salt

2 T honey

2 T apple cider vinegar

1 T Dijon mustard

Blend for 1 min.  With motor running slowly drizzle 1 C of safflower oil, then 1/8 C lemon juice, then 1 more C of safflower oil.  Continue blending until emulsified.  This won’t keep forever so store in frig and use within 2 weeks.

Interesting note on butter….so a patient went to his doc having allergy-type symptoms and said the only thing was that he was using a different brand of butter.  The doc called the manufacturing facility and learned they put a a thin layer of crushed shellfish on the butter to help keep it’s shape when it’s warmed.  The man was allergic to shell fish.

Until the food industry is required to honestly label ALL ingredients (even things like minute amounts of shellfish used for shape) patients will struggle with figure out why they react to so many things.

http://www.sciencemag.org/news/2018/09/evidence-based-medicine-group-turmoil-after-expulsion-co-founder

Evidence-based medicine group in turmoil after expulsion of co-founder

By Martin Enserink Sep. 16, 2018

A bitter dispute with one of its co-founders has plunged Cochrane, an international network of scientists promoting evidence-based medicine, into a crisis on the eve of an international gathering that marks its 25th anniversary. Late last week, a narrow majority of the organization’s Governing Board apparently decided to end the Cochrane membership of Peter Gøtzsche, director of the Nordic Cochrane Centre in Copenhagen and a member of the board himself, for causing “disrepute” to the organization. Four other board members then resigned in protest.

Gøtzsche announced his own expulsion in a three-page statement issued on Friday that said Cochrane was going through a “moral governance crisis.”  https://nordic.cochrane.org/news/moral-governance-crisis-growing-lack-democratic-collaboration-and-scientific-pluralism-0

In a phone interview with Science, Gøtzsche speculated that some foundations funding the collaboration had pressured it to get rid of him because of his highly critical views about pharma. He says he had become increasingly unhappy with what he describes as a “more commercial and more industry-friendly direction” in the organization. Gøtzsche had also launched a broadside against a favorable Cochrane analysis of vaccines against human papillomavirus (HPV), charging it may have overlooked side effects—a position embraced by antivaccine groups.

“As most people know, much of my work is not very favourable to the financial interests of the pharmaceutical industry,” Gøtzsche said in his statement. “Because of this Cochrane has faced pressure, criticism, and complaints. My expulsion is one of the results of these campaigns.” Gøtzsche says he does not have “a personal issue” with Cochrane CEO Mark Wilson but says many of the problems have gotten worse since Wilson arrived in 2012.

Wilson did not respond to an interview request today; neither did the Governing Board’s two co-chairs, Martin Burton and Marguerite Koster. Burton referred the inquiry to a Cochrane spokesperson, who did not answer emailed questions today. A short statement from Burton and Koster on Saturday did not mention Gøtzsche by name or the expulsion, but it said the board had “considered … the findings of an independent review and additional complaints related to the conduct of a Member.” They said this was “an ongoing process” and that more details would follow.  https://www.cochrane.org/news/message-governing-board

Gøtzsche’s expulsion was confirmed by the four resigning board members in a statement sent to Science by one of them, Gerald Gartlehner of Danube University in Krems, Austria.  https://blogs.bmj.com/bmjebmspotlight/files/2018/09/Why-we-resigned.pdf

“We consider the Board’s use of its authority to expel Peter from Cochrane to be disproportionate,” says the statement, which did not explain what Gøtzsche was punished for. “We believe that the expulsion of inconvenient members from the Collaboration goes against Cochrane ethos and neither reflects its founding spirit nor promotes the Collaboration’s best interests.”

The drama unfolded just as almost 1300 scientists from 57 countries were beginning to gather in Edinburgh for the Cochrane Colloquium, an annual scientific meeting that officially opened today. Cochrane, formerly known as the Cochrane Collaboration, is a nonprofit organization that produces literature reviews on medical interventions and diagnostics, which are published in the Cochrane Library to help medical professionals make evidence-based decisions. Gøtzsche helped found the organization in 1993 and started the Nordic Cochrane Center that same year. Today, Cochrane has a network of many thousands of volunteer reviewers as well as independent Cochrane Groups in 43 countries; it does not accept industry money, but it is supported primarily by government agencies, including the U.S. National Institutes of Health and the U.K. National Institute for Health Research.  https://www.cochrane.org/about-us/our-funders-and-partners

“If they can’t tolerate a few disagreements or a few headaches, that is a problem.”
David Hammerstein Mintz, former Cochrane Governing Board member

Both within and outside of Cochrane, Gøtzsche is widely known for his fierce attacks on the pharmaceutical industry and his criticism of medical interventions he deems useless or harmful. He wrote a controversial book about what he says is the overuse of mammography in breast cancer screening,   https://www.amazon.com/Mammography-Screening-Truth-Lies-Controversy/dp/1846195853  and, in another book, likened the pharmaceutical industry to “organized crime.”  http://www.deadlymedicines.dk/books/

He has often been critical of Cochrane as well. In a statement written for his 2017 election to the board, Gøtzsche listed a litany of “pretty widespread concerns” he wanted to address, including the concentration of power at the Central Executive Team in London and the fact that “collaboration” had been dropped from the group’s name.  https://community.cochrane.org/sites/default/files/uploads/inline-files/Gotzche%20Peter%20-Application_1.pdf

“The Cochrane Collaboration is now run much more as a business with a brand than it was just a few years ago,” he wrote.

Gøtzsche says the co-chairs convinced a majority of Cochrane’s board of the “disrepute” charge during a 6-hour meeting on Thursday that Gøtzsche was asked not to attend. All other 12 board members attended; of those, six supported a decision to remove Gøtzsche, five opposed it, and one abstained, according to the statement by the four departing members. One source with knowledge of the proceedings wrote in an email to Science that co-chairs justified his expulsion “in a very generic, general manner by his ‘behaviour’ that hurt the image of Cochrane.”

Gøtzsche says the decision is likely related to a frontal attack on a Cochrane review about vaccines against HPV, a cancer-causing virus, that he and two co-authors published in July.

The review, published in May in the Cochrane Library by researchers from Belgium and the United Kingdom, supported the mainstream view that such vaccines can prevent precancerous lesions in adolescent girls and young women. In their criticism, published in BMJ Evidence-Based Medicine, Gøtzsche, together with Lars Jørgensen of the Nordic Cochrane Centre and Tom Jefferson of the University of Oxford in the United Kingdom, argued that the review

missed nearly half of the eligible trials,” “ignored evidence of bias,” and did an incomplete assessment of the vaccine’s side effects. The review didn’t constitute the “trusted evidence” promised in Cochrane’s official motto, they said.  https://ebm.bmj.com/content/early/2018/07/27/bmjebm-2018-111012.long

After an investigation, Cochrane Library editors acknowledged in a 30-page response that the review had missed some trials, but said this made little or no difference to the main outcome and that the criticism was wrong on many other points.  https://www.cochrane.org/sites/default/files/public/uploads/cochrane_hpv_response_3sep18.pdf

“There is already a formidable and growing anti-vaccination lobby. If the result of this controversy is reduced uptake of the vaccine among young women, this has the potential to lead to women suffering and dying unnecessarily from cervical cancer,” they wrote.

In a response published on Friday, the editors of BMJ Evidence-Based Medicine defended publishing the trio’s broadside, saying it “provokes healthy debate.”

“Academic freedom means communicating ideas, facts and criticism without being censored, targeted or reprimanded,” they argued.  https://ebm.bmj.com/content/early/2018/09/12/bmjebm-2018-111108

Within a scientific organization such as Cochrane, discussion and dissent should be possible, says David Hammerstein Mintz, a consumer advocate, former member of the European Parliament from Spain, and one of the four departing board members. “If they can’t tolerate a few disagreements or a few headaches, that is a problem,” he says.

Posted in: Scientific Community
doi:10.1126/science.aav4490

_________________

**Comment**

The plot thickens.

 

 

c539767d-ca8c-484c-8115-9ad9d27e50be-original

_________________

**Comment**

One of the burning questions which desperately needs an answer:  is Lyme and the other tick borne illnesses persistent/chronic?

All the climate data in the world is not going to answer this.

Until this question is settled once and for all, patients WILL NOT get properly diagnosed or treated.  They also will not get any help from their medical insurance which is hiding behind this repudiated PTLDS diagnosis.  

This singular question is what is driving the lack of care along with not being able to effectively test for these pathogens and being honest about all the possible routes of transmission (sexual, congenital, via breastmilk, via other insects, etc)

For more on Lyme persistence:  https://madisonarealymesupportgroup.com/2015/09/19/proof-of-borrelia-persistence/

https://madisonarealymesupportgroup.com/2018/07/23/exploring-the-controversial-concept-of-chronic-lyme-disease/

http://norvect.no/230-peer-reviewed-studies-show-evidence-of-persistent-lyme-disease/

http://www.ilads.org/ilads_news/wp-content/uploads/2017/02/CLDList-ILADS.pdf (700 peer-reviewed articles showing persistence)

https://madisonarealymesupportgroup.com/2016/08/09/dr-paul-duray-research-fellowship-foundation-some-great-research-being-done-on-lyme-disease/ The work of Dr. Elizabeth Burgess DVM PhD in 1990 showed that dogs infected with LD were transmitting and infecting female dogs through sexual transmission, proof in humans is lacking. Pathologist Alan McDonald found B. burgdorferi and B. mayonii in the testicle and brain of a man who had been treated nearly continuously on antibiotics for the last seven years of his life. Grier states the case for sexual transmission is stronger than ever.

https://madisonarealymesupportgroup.com/2018/06/19/33-years-of-documentation-of-maternal-child-transmission-of-lyme-disease-and-congenital-lyme-borreliosis-a-review/

https://madisonarealymesupportgroup.com/2018/06/28/the-science-isnt-settled-on-chronic-lyme/

And of course, little to nothing has been done on the other tick-borne pathogen infections.  How many of them are persistent?  This question is so crucial because it would explain why thousands and thousands continue to relapse even on appropriate treatment.

 

 

 

 

 

**Please see independent tick researcher John Scott’s comment regarding climate change and tick expansion after the article.**

https://www.lymedisease.org/lyme-carditis-heart-block/

Lyme Carditis: Heart Block and Other Complications of Lyme Disease
Dr-Adrian-Cynthia2-300x219

by Adrian Baranchuk, MD, FACC ,FRCPC, FCCS, and Cynthia Yeung, BSc

The incidence of Lyme disease, a tick-borne bacterial infection, is rapidly increasing in North America. Risk modeling suggests that the incidence of Lyme disease will continue to rise as the migratory birds that are responsible for transmitting the Ixodes tick are affected by climate change and consequently, contribute to the expansion of at-risk regions. Lyme disease can affect many organ systems, including the heart, nerves, and joints.

In this article, the authors intend to highlight one of the most dramatic complications of Lyme disease, early dissemination Lyme carditis.

How Common Are Lyme Disease And Lyme Carditis?

Lyme disease is the most commonly reported vector-borne disease in North America, with an annual incidence of approximately 25, 000 confirmed cases in the United States. However, estimates suggest that the true incidence is closer to 300, 000 cases annually. Lyme disease affects the heart in 0.3-10% of cases.

Lyme Carditis: How Spirochetes Affect The Heart

In Lyme carditis, Borrelia burgdorferi (the spirochete responsible for Lyme disease) directly affects the heart. Damage to the heart tissue occurs from the direct invasion by the bacteria, as well as from the body’s exaggerated immune response to the infection.

In 90% of cases, the most common consequence of Lyme carditis is heart block. Electrical signals from the upper chambers of the heart are not properly relayed to the lower chambers of the heart, which can dramatically slow down the heart rate.

The severity of the heart block can fluctuate rapidly and the progression to complete heart block can be fatal. Importantly, the heart block in Lyme carditis can be transient and usually resolves with antibiotic therapy. Additionally, Lyme carditis can affect other parts of the heart’s conduction system, as well as the heart’s muscle, valves, and outer layer of the heart wall.

Symptoms Of Lyme Carditis

Patients with Lyme carditis may report light-headedness, fainting, shortness of breath, palpitations, and/or chest pain. Conversely, patients with Lyme carditis may also experience no symptoms, which contributes to the elusive nature of the diagnosis.

Systematic Approach For Lyme Carditis

To help healthcare providers consider Lyme carditis as a potential cause for heart block, our research team developed the Suspicious Index in Lyme Carditis (SILC) score.

It allots points for specific risk factors. The resulting score classifies patients into low, intermediate, and high-risk categories for the likelihood that the heart block is due to Lyme carditis. The variables in the SILC score can be associated with the mnemonic “CO-STAR”: Constitutional symptoms, Outdoor activity/endemic area, Sex (male), Tick bite, Age (< 50 years), and Rash.

Table 1. The Suspicious Index in Lyme Carditis (SILC) score evaluates the likelihood that a patient’s high-degree heart block is caused by Lyme carditis. The total score indicates low (0-2), intermediate (3-6), or high (7-12) suspicion of Lyme carditis.

Variable                                                               Value
Age < 50 years                                                     1
Male                                                                     1
Outdoor activity/endemic area                             1
Constitutional symptoms*                                    2
Tick bite                                                              3
Erythema migrans rash                                    4

* fever, malaise, arthralgia, and dyspnea

Patients with high-degree heart block and a SILC score of three or higher should be investigated immediately for Lyme disease. They should also receive antibiotic treatment while awaiting the results of testing.

Importance Of Prompt Recognition And Treatment Of Lyme Carditis

The standard protocol for high-degree heart block calls for implanting a permanent pacemaker. However, the heart block in Lyme carditis will most likely resolve with antibiotic therapy. Thus, identifying Lyme carditis as the underlying cause of the heart block can prevent the unnecessary implantation of permanent pacemakers.

The battery of a pacemaker lasts 7-10 years. Thus, a missed diagnosis could subject an otherwise young, healthy patient to 5-7 battery replacements over a lifetime—with each procedure bringing potential adverse events. These risks associated with the initial pacemaker implantation can be mitigated by intravenous and oral antibiotic treatment for heart block caused by Lyme carditis.

Educating Healthcare Providers

We aim to raise awareness about the cardiac manifestations of Lyme disease in endemic areas, so that healthcare providers are educated and alert about Lyme carditis. The conduction disorders associated with Lyme carditis can progress quickly. Patients often seek medical attention several times before Lyme carditis is suspected. The prompt diagnosis and treatment of Lyme carditis is essential to prevent unnecessary implantation of permanent pacemakers and further complications of Lyme disease.

Additional resources

  1. Wan D, Baranchuk A. Lyme carditis and atrioventricular block. CMAJ 2018;190:E622.
  2. Fuster LS, Gul EE, Baranchuk A. Electrocardiographic progression of acute Lyme disease. Am J Emerg Med 2017;35:1040 e5-1040 e6.
  3. Wan D, Blakely C, Branscombe P, Suarez-Fuster L, Glover B, Baranchuk A. Lyme Carditis and High-Degree Atrioventricular Block. Am J Cardiol 2018;121:1102-1104.

Dr. Baranchuk, a cardiologist and professor of medicine at Queen’s University, Kingston, Canada, is one of the world’s leading experts on Lyme carditis. Cynthia Yeung is a medical student.

____________________

https://www.thewhig.com/2018/02/05/letters-to-the-editor-feb-5/wcm/04cb0a0c-5253-8a4b-1f34-ca2b8ae54057

Birds, not climate change, brought ticks

Re: “Balance key to addressing climate change: expert,” Jan. 19.

I do not agree with Roberta Bondar’s statement: “The migration of deer ticks [blacklegged ticks] into the Kingston area, and the increased incidents of Lyme disease is an example of the kind of environmental changes that climate change is bringing.”

My peer-reviewed scientific research shows that migratory songbirds import blacklegged tick larvae and nymphs into Canada, and are widely dispersing them countrywide. In fact, a heavily tick-infested songbird can initiate a new blacklegged tick population. The number of immature blacklegged ticks on migratory song birds has remained constant for decades — long before climate change was coined. Furthermore, the adult female blacklegged tick does not migrate at all, and crawls a maximum of six metres in her lifetime.

I believe federally funded researchers who publish peer-reviewed papers on tick expansion numbers, ascribed to being caused by climate change, are wasting millions of taxpayer dollars. Moreover, their research is not helping patients get diagnosed and treated in a timely manner. Alarmingly, we have 3,000 patients going to the United States for diagnosis and treatment of Lyme disease and associated tick-borne diseases.

Any daily temperature increases are not putting any extinction stressors on the blacklegged female. She lays her eggs in the cool, moist leaf litter, where she has typically laid them for millennia, and is very comfortable in this microhabitat. She does not have extinction stress in this environment and, thus, does not lay more eggs. The seemingly more ticks in the Kingston area, and everywhere else, is not because of climate changing. In reality, public awareness is the key factor because more people, veterinarians and pet groomers are looking for them.

John D. Scott

Fergus, Ontario

Please know there’s a ton of money when it is ear-marked with the words “climate change,” but regarding tick expansion and therefore the spread of Lyme, it isn’t being honest and it’s taking valuable resources and money away from things that really matter.  Scott goes as far to say it’s a nefarious plot protecting authorities from the lack of helpful research and care for patients that’s occurred over the span of 40 years.

http://www.dutchessny.gov/CountyGov/Departments/Legislature/2017Auerbach.pdf This pdf by Lyme Advocate Jill Auerbach shows that while there were only 5,700 cases of WNV in 2012, research dollars were $29 million, whereas, Lyme cases in 2012 were 312,000 but received only $25 million.  Another stark contrast is Hepatitis C in 2012 with 1,300 cases but with $112 million in research dollars.

While the number of the infected continue to soar, the research dollars for Lyme are radically reduced in successive years.  Go here for a quick table comparing research dollars for various diseases:  https://madisonarealymesupportgroup.com/2018/09/17/study-shows-tick-infection-transmission-potential-for-both-dtv-wnv/

THIS DOES NOT EVEN INCLUDE OTHER TICK-BORNE DISEASES

Don’t kid yourself.  Words mean things and any research ear marked with the words “climate change” have not and will not help patients one iota.

For more:  https://madisonarealymesupportgroup.com/2018/08/13/study-shows-lyme-not-propelled-by-climate-change/

https://madisonarealymesupportgroup.com/2017/08/14/canadian-tick-expert-climate-change-is-not-behind-lyme-disease/

 

 

 

https://www.liebertpub.com/doi/abs/10.1089/vbz.2017.2224#utm_source=ETOC&utm_medium=email&utm_campaign=vbz

Generation of a Lineage II Powassan Virus (Deer Tick Virus) cDNA Clone: Assessment of Flaviviral Genetic Determinants of Tick and Mosquito Vector Competence

Kenney Joan L. , Anishchenko Michael , Hermance Meghan , Romo Hannah , Chen Ching-I , Thangamani Saravanan , and Brault Aaron C.
Published Online:1 Jul 2018https://doi.org/10.1089/vbz.2017.2224

Abstract

The Flavivirus genus comprises a diverse group of viruses that utilize a wide range of vertebrate hosts and arthropod vectors. The genus includes viruses that are transmitted solely by mosquitoes or vertebrate hosts as well as viruses that alternate transmission between mosquitoes or ticks and vertebrates. Nevertheless, the viral genetic determinants that dictate these unique flaviviral host and vector specificities have been poorly characterized. In this report, a cDNA clone of a flavivirus that is transmitted between ticks and vertebrates (Powassan lineage II, deer tick virus [DTV]) was generated and chimeric viruses between the mosquito/vertebrate flavivirus, West Nile virus (WNV), were constructed. These chimeric viruses expressed the prM and E genes of either WNV or DTV in the heterologous (from one species to another) nonstructural (NS) backbone. Recombinant chimeric viruses rescued from cDNAs were characterized for their capacity to grow in vertebrate and arthropod (mosquito and tick) cells as well as for in vivo vector competence in mosquitoes and ticks.

Results demonstrated that the NS elements were insufficient to impart the complete mosquito or tick growth phenotypes of parental viruses; however, these NS genetic elements did contribute to a 100- and 100,000-fold increase in viral growth in vitro in tick and mosquito cells, respectively. Mosquito competence was observed only with parental WNV, while infection and transmission potential by ticks were observed with both DTV and WNV-prME/DTV chimeric viruses. These data indicate that NS genetic elements play a significant, but not exclusive, role for vector usage of mosquito- and tick-borne flaviviruses.

________________

**Comment**

I’m no microbiologist and without the full article and better understanding of what this NS backbone is, 

The study shows 4 things:

  1.  The NS elements gave a 100 fold “test tube” increase in viral growth in tick cells.  These organisms are extremely fastidious and difficult to study in a lab.  It’s even tougher to figure out how this plays out in the human body.
  2. INFECTION & TRANSMISSION potential by ticks was observed with both DTV and WNV.  Read that sentence again.
  3. Why didn’t this make the news?
  4. Mosquitoes are nasty but ticks are a whole other monster.  Mosquito research gets all the money.  Why?

http://www.dutchessny.gov/CountyGov/Departments/Legislature/2017Auerbach.pdf  This pdf by Lyme Advocate Jill Auerbach shows that while there were only 5,700 cases of WNV in 2012, research dollars were $29 million, whereas, Lyme cases in 2012 were 312,000 but received only $25 million.  While the number of the infected continue to soar the research dollars for Lyme are radically reduced in successive years:

Disease New Cases (annual) NIH Funding
 

Hepatitis C 2012

 

1,300

 

$112 million

West Nile Virus 2012

5,700

$29 million

HIV/AIDS 2012

56,000

$3 billion (11% total NIH budget)

Influenza 2012

73,000

$251 million

Lyme disease 2012

312,000

$25 million

Lyme disease 2013

363,070

$20 million

*Lyme disease 2004             198,040                                  $34.4 million

Disease

      New Cases 2015

CDC funding 2016

Lyme Disease

           380,690  (10 x 38,069)
2016 numbers not yet available

 $10 million

This does NOT include other Tick-borne diseases

Houston, we have a problem.